Sale!

ALG2 Gene Glycosylation Disorder Type 1I Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The ALG2 Gene Glycosylation Disorder Type 1I Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to detect mutations in the ALG2 gene, which can lead to a rare condition known as Congenital Disorders of Glycosylation Type 1I (CDG-1I). This condition is part of a group of inherited metabolic disorders that affect the process of glycosylation—the attachment of sugar molecules to proteins and lipids, which is crucial for their proper function. Mutations in the ALG2 gene disrupt this process, leading to a wide range of symptoms, including developmental delay, neurological issues, and digestive problems.

The test, priced at 4400 AED, involves collecting a DNA sample, usually through a blood draw, and analyzing it for specific genetic mutations associated with the disorder. It is particularly recommended for individuals with clinical symptoms of CDG-1I or those with a family history of the condition. Early and accurate diagnosis through the ALG2 Gene Glycosylation Disorder Type 1I Genetic Test can be critical for the management and treatment of the condition, allowing for tailored therapies and interventions that can significantly improve the quality of life for affected individuals. DNA Labs UAE, with its state-of-the-art facilities and expert team, ensures a reliable and efficient testing process, offering crucial insights into this complex genetic disorder.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

ALG2 Gene Glycosylation Disorder Type 1I Genetic Test

Welcome to DNA Labs UAE, where we offer the ALG2 Gene Glycosylation Disorder Type 1I Genetic Test. In this blog, we will provide detailed information about the test, including its components, cost, symptoms, diagnosis, and more.

Test Name: ALG2 Gene Glycosylation Disorder Type 1I Genetic Test

Components: Blood or Extracted DNA or One drop Blood on FTA Card

Price: 4400.0 AED

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Method: NGS Technology

Test Type: Metabolic Disorders

Doctor: General Physician

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for ALG2 Gene Glycosylation Disorder Type 1I NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1I.

Test Details

ALG2 gene glycosylation disorder type 1I is a rare genetic disorder that affects the glycosylation process in the body. Glycosylation is the process of attaching sugar molecules to proteins or lipids, which is important for their proper functioning.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA to identify genetic variations or mutations. It allows for the simultaneous sequencing of multiple genes, providing a comprehensive analysis of the genetic information.

In the context of ALG2 gene glycosylation disorder type 1I, NGS genetic testing can be used to identify specific mutations or variations in the ALG2 gene that are associated with the disorder. This information can help in confirming a diagnosis, understanding the underlying genetic cause, and providing appropriate genetic counseling or treatment options.

NGS genetic testing is becoming increasingly popular due to its ability to analyze multiple genes simultaneously, providing a more comprehensive and efficient approach to genetic testing. It has revolutionized the field of genetic research and diagnosis, allowing for more accurate and precise identification of genetic disorders.

Test Name ALG2 Gene Glycosylation disorder type 1I Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Metabolic Disorders
Doctor General Physician
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for ALG2 Gene Glycosylation disorder type 1I NGS Genetic DNA Test A Genetic Counselling session to draw a pedigree chart of family members affected with Glycosylation disorder type 1I
Test Details

ALG2 gene glycosylation disorder type 1I is a rare genetic disorder that affects the glycosylation process in the body. Glycosylation is the process of attaching sugar molecules to proteins or lipids, which is important for their proper functioning.

NGS (Next-Generation Sequencing) genetic testing is a method used to analyze an individual’s DNA to identify genetic variations or mutations. It allows for the simultaneous sequencing of multiple genes, providing a comprehensive analysis of the genetic information.

In the context of ALG2 gene glycosylation disorder type 1I, NGS genetic testing can be used to identify specific mutations or variations in the ALG2 gene that are associated with the disorder. This information can help in confirming a diagnosis, understanding the underlying genetic cause, and providing appropriate genetic counseling or treatment options.

NGS genetic testing is becoming increasingly popular due to its ability to analyze multiple genes simultaneously, providing a more comprehensive and efficient approach to genetic testing. It has revolutionized the field of genetic research and diagnosis, allowing for more accurate and precise identification of genetic disorders.